Liaoning: Where Industrial Grit Meets Untamed Wilderness
SHENYANG, China, July 30, 2026 /PRNewswire/ -- Nestled in the strategic gateway to northeastern China, Liaoning is home to a civilization spanning more than 5,000 years. The Niuheliang Hongshan culture site marks the dawn of Chinese prehistoric...
PTCL Group Leadership Meets FinVolution at MWC Shanghai 2026 to Explore Credit Technology for Financial Inclusion in Pakistan
SHANGHAI, July 14, 2026 /PRNewswire/ -- Leading fintech company FinVolution Group (NYSE: FINV) met with senior leadership of PTCL Group — Pakistan's largest integrated telecommunications and ICT company — at Mobile World Congress (MWC) Shanghai 2026...
Where Zongzi Meets Confucian Wisdom: Splendid Dragon Boat Celebrations at Guiyang Confucius Academy
GUIYANG, China, June 25, 2026 /PRNewswire/ -- A news report by Huanqiu.com From June 14 to 19, Guiyang Confucius Academy leveraged the festive occasion to host a rich array of Dragon Boat Festival activities including folk custom experiences,...
Shrewsbury International School Hong Kong Meets Overwhelming Demand for Global Pathway with Additional Year 7 Class
HONG KONG, June 22, 2026 /PRNewswire/ -- Following the highly successful launch of its Key Stage 3 in March, Shrewsbury International School Hong Kong has officially accelerated its mission to develop into a premium through-train school. At its...
Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight
BEIJING and BRIDGEWATER, N.J., June 12, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (hereinafter "Gan & Lee", stockcode: 603087.SH) announced that two of its core pipeline products in the fields of diabetes and obesity treatment have...
eSUN Prime Day Meets the World Cup: Why PETG is Dominating 3D Printing
WUHAN, China, June 5, 2026 /PRNewswire/ -- As Amazon Prime Day aligns with the World Cup, a global shopping celebration begins. eSUN is launching massive promotions across its U.S., U.K., and German Amazon stores, offering up to 60% off on a wide...
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application...
BGM0504 Achieves 19.3% Robust Weight Reduction, 16.5 cm Waist Circumference Decrease, Significant SBP/DBP Improvements of 22.9/12.9 mmHg, and 70.7 μmol/L Uric Acid Reduction; Phase III Trial Meets Primary Endpoint and All Key Secondary Endpoints
SUZHOU, China, May 5, 2026 /PRNewswire/ -- BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as " BrightGene Bio-Medical" or "the Company") announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent...
Baby Shark Meets Generative AI in a New Interactive Experience
Early-bird tickets now on sale for a generative AI–powered exhibition featuring real-time character interaction Debuting June 18, the exhibition introduces AI-driven storytelling through live interactions with Baby Shark characters Download images...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection,...